Diet-Induced Microbiome's Impact on Heart Failure: A Double-Edged Sword

被引:5
|
作者
Rodrigues, Alexandre [1 ,2 ,3 ]
Goncalves, Alexandre [3 ,4 ]
Morais, Juliana [3 ,5 ]
Araujo, Ricardo [1 ,2 ]
Falcao-Pires, Ines [3 ,4 ]
机构
[1] Univ Porto, INEB Inst Biomed Engn, P-4200135 Porto, Portugal
[2] Univ Porto, i3S Inst Res & Innovat Hlth, P-4200135 Porto, Portugal
[3] Fac Med Univ Porto, Dept Surg & Physiol, P-4200319 Porto, Portugal
[4] Univ Porto, Dept Surg & Physiol, UnICRISE, Fac Med, P-4200319 Porto, Portugal
[5] Ctr Hlth Technol & Serv Res, CintesisRISE, P-4200450 Porto, Portugal
关键词
heart failure; HFrEF; HFpEF; microbiome; inflammation; diet; REDUCED EJECTION FRACTION; GUT MICROBIOTA; FATTY-ACIDS; INTESTINAL MICROBIOTA; MYOCARDIAL-INFARCTION; MEDITERRANEAN DIET; METABOLIC SYNDROME; RED MEAT; DISEASE; EPIDEMIOLOGY;
D O I
10.3390/nu15051223
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Heart failure (HF) is a debilitating disease with a significant clinical and economic impact worldwide. Multiple factors seem to increase the risk of developing HF, such as hypertension, obesity and diabetes. Since chronic inflammation plays a significant role in HF pathophysiology and gut dysbiosis is associated with low-grade chronic inflammation, the risk of cardiovascular diseases is likely modulated by the gut microbiome (GM). Considerable progress has been made in HF management. However, there is a need to find new strategies to reduce mortality and increase the quality of life, mainly of HFpEF patients, since its prevalence continues to rise. Recent studies validate that lifestyle changes, such as diet modulation, represent a potential therapeutic approach to improve several cardiometabolic diseases, although their effects on the GM and its indirect cardiac impact still warrant further research. Hence, in this paper, we aim to clarify the link between HF and the human microbiome.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Hashimoto's Thyroiditis: A "Double-Edged Sword" in Thyroid Carcinoma
    Xu, Jiangyue
    Ding, Ke
    Mu, Lan
    Huang, Jiangsheng
    Ye, Fei
    Peng, Yu
    Guo, Can
    Ren, Chutong
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] Inflammatory angiogenesis in atherogenesisa double-edged sword
    Ribatti, Domenico
    Levi-Schaffer, Francesca
    Kovanen, Petri T.
    ANNALS OF MEDICINE, 2008, 40 (08) : 606 - 621
  • [23] Extracellular Vesicles: A Double-Edged Sword in Sepsis
    Burgelman, Marlies
    Vandendriessche, Charysse
    Vandenbroucke, Roosmarijn E.
    PHARMACEUTICALS, 2021, 14 (08)
  • [24] Alcohol and the Cardiovascular System: A Double-Edged Sword
    Katsiki, Niki
    Tziomalos, Konstantinos
    Mikhailidis, Dimitri P.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (40) : 6276 - 6288
  • [25] Hyaluronan, a double-edged sword in kidney diseases
    Kaul, Aditya
    Singampalli, Kavya L.
    Parikh, Umang M.
    Yu, Ling
    Keswani, Sundeep G.
    Wang, Xinyi
    PEDIATRIC NEPHROLOGY, 2022, 37 (04) : 735 - 744
  • [26] Nicotine: A Double-Edged Sword in Atherosclerotic Disease
    Liu, Chun-Chieh
    Yeh, Hung-I
    ACTA CARDIOLOGICA SINICA, 2014, 30 (02) : 108 - 113
  • [27] Chemotherapy: a double-edged sword in cancer treatment
    Nafiseh Behranvand
    Farzad Nasri
    Reza Zolfaghari Emameh
    Pouria Khani
    Asieh Hosseini
    Johan Garssen
    Reza Falak
    Cancer Immunology, Immunotherapy, 2022, 71 : 507 - 526
  • [28] Viruses, apoptosis, and neuroinflammation—a double-edged sword
    Peter G. E. Kennedy
    Journal of NeuroVirology, 2015, 21 : 1 - 7
  • [29] Mast cells: A double-edged sword in cancer
    Derakhshani, Afshin
    Vahidian, Fatemeh
    Alihasanzadeh, Mohammad
    Mokhtarzadeh, Ahad
    Nezhad, Parisa Lotfi
    Baradaran, Behzad
    IMMUNOLOGY LETTERS, 2019, 209 : 28 - 35
  • [30] Angiotensin II: A double-edged sword in inflammation
    Suzuki, Y
    Ruiz-Ortega, M
    Egido, J
    JOURNAL OF NEPHROLOGY, 2000, 13 : S101 - S110